Search images on Google      Product Monograph

Active Ingredients:

• canakinumab, 150 MG/ML

DIN: 02460351

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC  –  official site

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AC - Interleukin inhibitors (ATC, WHO)
• L04AC08 - CANAKINUMAB (WHO)

Reference brand drug: Ilaris

 

External Links for Ilaris:

Search on Google

• Ilaris side effects
• Ilaris dosage
• canakinumab side effects
• canakinumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find ilaris photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.